Equities

Abingdon Health PLC

ABDX:LSE

Abingdon Health PLC

Health CareMedical Equipment and Services
  • Price (GBX)9.25
  • Today's Change0.00 / 0.00%
  • Shares traded335.35k
  • 1 Year change-7.50%
  • Beta-0.4373
Data delayed at least 15 minutes, as of Oct 04 2024 16:26 BST.
More ▼

Profile data is unavailable for this security.

About the company

Abingdon Health plc is an international lateral flow contract research (CRO) and contract development and manufacturing organization (CDMO). The Company is engaged in offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. It focuses on supporting the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas, such as infectious disease, clinical testing including companion diagnostics, and others. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests. It also specializes in meeting compliance requirements in the international IVD and medical device markets.

  • Revenue in GBP (TTM)5.34m
  • Net income in GBP-2.24m
  • Incorporated2008
  • Employees82.00
  • Location
    Abingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
  • Phone+44 19 0440 6050Fax+44 19 0446 2122
  • Websitehttps://www.abingdonhealth.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ABDX:LSE since
announced		Transaction
value
Compliance Solutions Group LLCDeal completed24 Jul 202424 Jul 2024Deal completed-13.95%4.12m
Data delayed at least 15 minutes, as of Oct 04 2024 16:26 BST.

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Rua Life Sciences PLC2.19m-1.44m9.00m33.009.00m33.00
Genincode PLC2.60m-5.94m9.29m36.009.29m36.00
Genedrive PLC272.00k-5.00m9.91m43.009.91m43.00
Renalytix PLC2.59m-35.22m13.84m80.0013.84m80.00
Verici DX PLC3.30m-3.66m15.81m19.0015.81m19.00
Inspiration Healthcare Group PLC34.30m-9.76m17.04m224.0017.04m224.00
Polarean Imaging PLC1.42m-6.51m17.08m29.0017.08m29.00
Abingdon Health PLC5.34m-2.24m17.91m82.0017.91m82.00
Ondine Biomedical Inc918.72k-8.03m18.15m43.0018.15m43.00
Belluscura PLC1.38m-14.18m21.71m35.0021.71m35.00
ANGLE plc2.02m-18.03m26.62m150.0026.62m150.00
Data as of Oct 04 2024. Currency figures normalised to Abingdon Health PLC's reporting currency: UK Pound GBX

Institutional shareholders

9.75%Per cent of shares held by top holders
HolderShares% Held
Hargreaves Lansdown Asset Management Ltd.as of 08 Sep 202310.43m8.23%
Unicorn Asset Management Ltd.as of 31 Jul 20241.93m1.52%
Data from 31 Jul 2024 - 01 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.